Pharmabiz

Obsidian Therapeutics enrols first patient in phase 1/2 Agni-01 study to evaluate Amsoki-cel in advanced melanoma

Obsidian Therapeutics enrols first patient in phase 1/2 Agni-01 study to evaluate Amsoki-cel in advanced melanoma: Cambridge, Massachusetts Saturday, August 8, 2026, 18:00 Hrs [IS ...
Pharmabiz

Emergent BioSolutions highlights for a cross-sector collaboration against biological threats in evolving global security environ

Emergent BioSolutions highlights for a cross-sector collaboration against biological threats in evolving global security environ: Gaithersburg, Maryland Saturday, August 8, 2026, ...
Pharmabiz

Kodiak Sciences completes enrollment in phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation

Kodiak Sciences completes enrollment in phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation: Palo Alto, California Saturday, August 8, 2026, 16:00 Hrs [IST] ...
Pharmabiz

Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers

Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers: Philadelphia, San Francisco Saturday, ...
Pharmabiz

Ministry of Ayush takes initiatives to promote production, quality of Ayush medicines

Ministry of Ayush takes initiatives to promote production, quality of Ayush medicines: Our Bureau, Mumbai Saturday, August 8, 2026, 13:30 Hrs [IST] Union Minister of State (I/C) f ...
Pharmabiz

NHA achieves milestone with 25 crore OPD registrations through ABHA-based Scan and Register Service

NHA achieves milestone with 25 crore OPD registrations through ABHA-based Scan and Register Service: Our Bureau, Mumbai In a significant ...
Pharmabiz

Evotec and Odyssey Therapeutics ink AI-enabled R&D collaboration in autoimmune and inflammatory diseases

Evotec and Odyssey Therapeutics ink AI-enabled R&D collaboration in autoimmune and inflammatory diseases: Hamburg, Germany Saturday, August 8, 2026, 15:00 Hrs [IST] Evotec SE, a l ...
Pharmabiz

Mediar Therapeutics inks collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases

Mediar Therapeutics inks collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases: Boston Saturday, August 8, 2026, 11:00 Hrs ...
Pharmabiz

Ractigen Therapeutics completes enrollment and first dosing in phase II trial of RAG-17 for SOD1-ALS

Ractigen Therapeutics completes enrollment and first dosing in phase II trial of RAG-17 for SOD1-ALS: Nantong, China Ractigen Therapeutic ...
Pharmabiz

UK MHRA grants marketing authorization to Novartis Rhapsido for adult patients with CSU with inadequate response to H1 antihistamine

UK MHRA grants marketing authorization to Novartis Rhapsido for adult patients with CSU with inadequate response to H1 antihistamine: London Saturday, August 8, 2026, 09:00 Hrs [I ...
Pharmabiz

Govt strengthens affordable healthcare ecosystem through NHM, AB PM-JAY: Anupriya Patel

Govt strengthens affordable healthcare ecosystem through NHM, AB PM-JAY: Anupriya Patel: Our Bureau, Mumbai Saturday, August 8, 2026, 13:15 Hrs [IST] Union minister of state for h ...
Pharmabiz

Lucid Diagnostics secures commercial coverage policy spanning multiple health plans for its EsoGuard esophageal DNA test

Lucid Diagnostics secures commercial coverage policy spanning multiple health plans for its EsoGuard esophageal DNA test: New York Saturday, August 8, 2026, 13:00 Hrs [IST] Lucid ...